carbachol has been researched along with Experimental Leukemia in 2 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oishi, K | 1 |
| Yoshizumi, T | 1 |
| Seki, N | 1 |
| Uchida, MK | 1 |
| Gale, RP | 1 |
| Zighelboim, J | 1 |
2 other studies available for carbachol and Experimental Leukemia
| Article | Year |
|---|---|
Carbachol-induced membrane ruffling and its desensitization in rat basophilic leukemia (RBL-2H3) cells transfected with m3 muscarinic acetylcholine receptors.
Topics: Actin Cytoskeleton; Actins; Animals; Basophils; beta-N-Acetylhexosaminidases; Calcium; Carbachol; Ce | 2004 |
Modulation of polymorphonuclear leukocyte-mediated antibody-dependent cellular cytotoxicity.
Topics: Acetylcholine; Aminophylline; Animals; Antibodies; Carbachol; Cholera; Colchicine; Cyclic AMP; Cycli | 1974 |